Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 584604, 13 pages
http://dx.doi.org/10.1155/2013/584604
Research Article

Gene Expression Profile of the A549 Human Non-Small Cell Lung Carcinoma Cell Line following Treatment with the Seeds of Descurainia sophia, a Potential Anticancer Drug

KM-Based Herbal Drug Research Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 305-811, Republic of Korea

Received 3 April 2013; Revised 27 May 2013; Accepted 5 June 2013

Academic Editor: Bo-Hyoung Jang

Copyright © 2013 Bu-Yeo Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Ghavami, M. R. Kazemali, and S. Sardari, “Informatics of drug synergism in naturally occurring anticancer agents,” Recent Patents on Anti-Cancer Drug Discovery, vol. 6, no. 1, pp. 26–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-S. Chia, J.-L. Du, W.-B. Hsu, A. Sun, C.-P. Chiang, and W.-B. Wang, “Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid,” BMC Cancer, vol. 10, article 175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Wagner and G. Ulrich-Merzenich, “Synergy research: approaching a new generation of phytopharmaceuticals,” Phytomedicine, vol. 16, no. 2-3, pp. 97–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Faivre, S. Djelloul, and E. Raymond, “New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors,” Seminars in Oncology, vol. 33, no. 4, pp. 407–420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sathornsumetee, “Therapeutic strategies to target multiple kinases in glioblastoma,” Anti-Cancer Agents in Medicinal Chemistry, vol. 11, no. 8, pp. 700–711, 2011. View at Google Scholar · View at Scopus
  6. Y. J. Lee, N. S. Kim, H. Kim et al., “Cytotoxic and anti-inflammatory constituents from the seeds of Descurainia sophia,” Archives of Pharmacal Ressearch, vol. 36, no. 5, pp. 536–541, 2013. View at Google Scholar
  7. Y. Q. Chen, R. Z. Li, and Y. W. Wang, “Identification of cardiac glycosides from the seeds of Descurainia sophia L. Webb,” Acta Pharmaceutica Sinica, vol. 16, no. 1, pp. 62–64, 1981. View at Google Scholar · View at Scopus
  8. K. Sun, X. Li, J.-M. Liu, J.-H. Wang, W. Li, and Y. Sha, “A novel sulphur glycoside from the seeds of Descurainia sophia (L.),” Journal of Asian Natural Products Research, vol. 7, no. 6, pp. 853–856, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Sun, X. Li, W. Li, J.-M. Liu, J.-H. Wang, and Y. Sha, “A new nor-lignan from the seeds of Descurainia sophia,” Natural Product Research, vol. 20, no. 6, pp. 519–522, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Sun, X. Li, W. Li, J. Wang, J. Liu, and Y. Sha, “Two new lactones and one new aryl-8-oxa-bicyclo[3,2,1]oct-3-en-2-one from Descurainia sophia,” Chemical and Pharmaceutical Bulletin, vol. 52, no. 12, pp. 1483–1486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. T. M. Ehrman, D. J. Barlow, and P. J. Hylands, “In silico search for multi-target anti-inflammatories in Chinese herbs and formulas,” Bioorganic and Medicinal Chemistry, vol. 18, no. 6, pp. 2204–2218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. J. Lee, J. Kim, J. M. Yi et al., “Anti-proliferative neolignans from Saururus chinensis against human cancer cell lines,” Biological & Pharmaceutical Bulletin, vol. 35, no. 8, pp. 1361–1366, 2012. View at Google Scholar
  13. A. Schroeder, O. Mueller, S. Stocker et al., “The RIN: an RNA integrity number for assigning integrity values to RNA measurements,” BMC Molecular Biology, vol. 7, article 3, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. B. M. Bolstad, R. A. Irizarry, M. Åstrand, and T. P. Speed, “A comparison of normalization methods for high density oligonucleotide array data based on variance and bias,” Bioinformatics, vol. 19, no. 2, pp. 185–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Ernst and Z. Bar-Joseph, “STEM: a tool for the analysis of short time series gene expression data,” BMC Bioinformatics, vol. 7, article 191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Raponi, Y. Zhang, J. Yu et al., “Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung,” Cancer Research, vol. 66, no. 15, pp. 7466–7472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Dennis Jr., B. T. Sherman, D. A. Hosack et al., “DAVID: database for annotation, visualization, and integrated discovery,” Genome Biology, vol. 4, no. 5, article P3, 2003. View at Google Scholar · View at Scopus
  18. B. R. Zeeberg, H. Qin, S. Narasimhan et al., “High-throughput GoMiner, an “industrial-strength” integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID),” BMC Bioinformatics, vol. 6, article 168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Supek, M. Bošnjak, N. Škunca, and T. Šmuc, “Revigo summarizes and visualizes long lists of gene ontology terms,” PLoS ONE, vol. 6, no. 7, Article ID e21800, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. L. Tarca, S. Draghici, P. Khatri et al., “A novel signaling pathway impact analysis,” Bioinformatics, vol. 25, no. 1, pp. 75–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Y. Lee, K. H. Song, I. Koo et al., “Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method,” Genomics, vol. 99, no. 6, pp. 347–354, 2012. View at Google Scholar
  22. S. Veerla and M. Höglund, “Analysis of promoter regions of co-expressed genes identified by microarray analysis,” BMC Bioinformatics, vol. 7, article 384, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. V. P. Sukhatme and B. Chan, “Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence,” FEBS Letters, vol. 586, no. 16, pp. 2389–2395, 2012. View at Google Scholar
  24. W. Zhao, L. Hu, J. Xu et al., “Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer,” Cancer Chemotherpy and Pharmacology, vol. 71, no. 5, pp. 1287–1295, 2013. View at Google Scholar
  25. C. Kiyohara, K. Takayama, and Y. Nakanishi, “Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis,” Lung Cancer, vol. 54, no. 3, pp. 267–283, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Lu, L. Ding, H. Hong, J. Hoggard, Q. Lu, and Y.-H. Chen, “Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway,” Experimental Cell Research, vol. 317, no. 13, pp. 1935–1946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Ji, Z. Wang, S. A. Perera et al., “Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models,” Cancer Research, vol. 67, no. 10, pp. 4933–4939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. A. Adjei, “The role of mitogen-activated ERK-kinase inhibitors in lung cancer therapy,” Clinical Lung Cancer, vol. 7, no. 3, pp. 221–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Mohan, S. I. Abdelwahab, S. C. Cheah et al., “Apoptosis effect of girinimbine isolated from Murraya koenigii on lung cancer cells in vitro,” Evididence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 689865, 12 pages, 2013. View at Publisher · View at Google Scholar
  30. Y. F. Ho, S. A. Karsani, W. K. Yong, and S. N. Abd Malek, “Induction of apoptosis and cell cycle blockade by helichrysetin in a549 human lung adenocarcinoma cells,” Evididence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 857257, 10 pages, 2013. View at Publisher · View at Google Scholar
  31. T. Choedon, D. Dolma, and V. Kumar, “Pro-apoptotic and anticancer properties of thapring—a Tibetan herbal formulation,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 320–326, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. F. A. Shepherd, J.-Y. Douillard, and G. R. Blumenschein Jr., “Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome,” Journal of Thoracic Oncology, vol. 6, no. 10, pp. 1763–1773, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Mazzoccoli, M. Grilli, S. Carughi et al., “Immune system alterations in lung cancer patients,” International Journal of Immunopathology and Pharmacology, vol. 16, no. 2, pp. 167–174, 2003. View at Google Scholar · View at Scopus